Does LORAZEPAM Cause Mobility decreased? 187 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 187 reports of Mobility decreased have been filed in association with LORAZEPAM (Lorazepam). This represents 0.6% of all adverse event reports for LORAZEPAM.
187
Reports of Mobility decreased with LORAZEPAM
0.6%
of all LORAZEPAM reports
134
Deaths
157
Hospitalizations
How Dangerous Is Mobility decreased From LORAZEPAM?
Of the 187 reports, 134 (71.7%) resulted in death, 157 (84.0%) required hospitalization, and 134 (71.7%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LORAZEPAM. However, 187 reports have been filed with the FAERS database.
What Other Side Effects Does LORAZEPAM Cause?
Drug ineffective (3,775)
Drug abuse (3,741)
Toxicity to various agents (2,836)
Completed suicide (2,340)
Off label use (2,178)
Somnolence (2,114)
Sopor (2,042)
Anxiety (1,573)
Fall (1,524)
Overdose (1,516)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which LORAZEPAM Alternatives Have Lower Mobility decreased Risk?
LORAZEPAM vs LORCASERIN
LORAZEPAM vs LORLATINIB
LORAZEPAM vs LORMETAZEPAM
LORAZEPAM vs LORNOXICAM
LORAZEPAM vs LOSARTAN